Notice of NHLBI Participation in PAR-19-135 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"

Notice Number: NOT-HL-18-665

Key Dates
Release Date: December 21, 2018

Related Announcements
PAR-19-135

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicantsthat the National Heart, Lung, and Blood Institute (NHLBI) will participate, effective immediately, in PAR-18-966 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools(R15 Clinical Trial Required)".

The following sections of PAR-18-966 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA):

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Drug Abuse (NIDA)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Heart, Lung, and Blood Institute(NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.393, 93.394, 93.395, 93.399, 93.865, 93.279, 93.173, 93.242, 93.853,93.837, 93.838, 93.839, 93.840, 93.233

Section VII. Agency Contacts

Scientific/Research Contact(s)

Aaron D. Laposky, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7837
Email: laposkya@nhlbi.nih.gov

Financial/Grants Management Contact(s)

Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0186
Email:agrestia@nhlbi.nih.gov

Inquiries

Please direct all inquiries to:

Aaron D. Laposky, PhD

National Heart, Lung, and Blood Institute (NHLBI)

Telephone: 301-827-7837

Email: laposkya@nhlbi.nih.gov